Acute graft-versus-host disease after allogeneic bone marrow transplantation.

In 25 patients receiving allogeneic bone marrow transplants methotrexate was used to prevent acute graft-versus-host disease (GVHD). Acute GVHD, grades 2 to 4, developed in only 5 (20%) of the patients. The incidence of acute GVHD in other series of recipients of bone marrow transplants has ranged f...

Full description

Saved in:
Bibliographic Details
Main Authors: Perreault, C., Gyger, M., Boileau, J., Bonny, Y., Cousineau, S., Lacombe, M., Lavallee, R., Tawil, E., D'Angelo, G.
Format: Artigo
Language:Inglês
Published: 1983
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC1875857/
https://ncbi.nlm.nih.gov/pubmed/6367917
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items